We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
AstraZeneca and eko.ai attempting to meet ‘huge need’ for better heart failure diagnosis
Joris Silon, senior vice president, global cardiovascular, renal and metabolism (CVRM) at AstraZeneca’s biopharmaceuticals business unit (Credit: AstraZeneca)